Shanghai Junshi Biosciences Co., Ltd. Class H (HK:1877) has released an update.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Shanghai Junshi Biosciences Co., Ltd. has announced a strategic license and cooperation agreement with JSIAMA for the IAMA-001 Nasal Spray Project, allowing exclusive rights to the Greater China region and collaborative development rights globally. The deal includes upfront payments, milestone payments, and royalties based on the project’s progress and sales. This partnership marks a significant step for Junshi Biosciences in expanding its portfolio and presence in the biopharmaceutical industry.
For further insights into HK:1877 stock, check out TipRanks’ Stock Analysis page.